Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006;10(3):R70.
doi: 10.1186/cc4912. Epub 2006 May 9.

Kinetic Bed Therapy to Prevent Nosocomial Pneumonia in Mechanically Ventilated Patients: A Systematic Review and Meta-Analysis

Affiliations
Free PMC article
Review

Kinetic Bed Therapy to Prevent Nosocomial Pneumonia in Mechanically Ventilated Patients: A Systematic Review and Meta-Analysis

Anthony Delaney et al. Crit Care. .
Free PMC article

Abstract

Introduction: Nosocomial pneumonia is the most important infectious complication in patients admitted to intensive care units. Kinetic bed therapy may reduce the incidence of nosocomial pneumonia in mechanically ventilated patients. The objective of this study was to investigate whether kinetic bed therapy reduces the incidence of nosocomial pneumonia and improves outcomes in critically ill mechanically ventilated patients.

Methods: We searched Medline, EMBASE, CINAHL, CENTRAL, and AMED for studies, as well as reviewed abstracts of conference proceedings, bibliographies of included studies and review articles and contacted the manufacturers of medical beds. Studies included were randomized or pseudo-randomized clinical trials of kinetic bed therapy compared to standard manual turning in critically ill mechanically ventilated adult patients. Two reviewers independently applied the study selection criteria and extracted data regarding study validity, type of bed used, intensity of kinetic therapy, and population under investigation. Outcomes assessed included the incidence of nosocomial pneumonia, mortality, duration of ventilation, and intensive care unit and hospital length of stay.

Results: Fifteen prospective clinical trials were identified, which included a total of 1,169 participants. No trial met all the validity criteria. There was a significant reduction in the incidence of nosocomial pneumonia (pooled odds ratio (OR) 0.38, 95% confidence interval (CI) 0.28 to 0.53), but no reduction in mortality (pooled OR 0.96, 95%CI 0.66 to 1.14), duration of mechanical ventilation (pooled standardized mean difference (SMD) -0.14 days, 95%CI, -0.29 to 0.02), duration of intensive care unit stay (pooled SMD -0.064 days, 95% CI, -0.21 to 0.086) or duration of hospital stay (pooled SMD 0.05 days, 95% CI -0.18 to 0.27).

Conclusion: While kinetic bed therapy has been purported to reduce the incidence of nosocomial pneumonia in mechanically ventilated patients, the overall body of evidence is insufficient to support this conclusion. There appears to be a reduction in the incidence of nosocomial pneumonia, but no effect on mortality, duration of mechanical ventilation, or intensive care or hospital length of stay. Given the lack of consistent benefit and the poor methodological quality of the trials included in this analysis, definitive recommendations regarding the use of this therapy cannot be made at this time.

Figures

Figure 1
Figure 1
QUOROM Flow diagram summarizing trial flow and reasons for exclusion of studies. RCT, randomized clinical trial.
Figure 2
Figure 2
Forest plot showing the effect of kinetic bed therapy on nosocomial pneumonia
Figure 3
Figure 3
Forest plot showing the effect of kinetic bed therapy on mortality. CI, confidence interval.
Figure 4
Figure 4
Forest plot showing the effect of kinetic bed therapy on duration of mechanical ventilation. CI, confidence interval.
Figure 5
Figure 5
Forest plot showing the effect of kinetic bed therapy on intensive care unit length of stay. CI, confidence interval.
Figure 6
Figure 6
Forest plot showing the effect of kinetic bed therapy on hospital length of stay. CI, confidence interval.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles

References

    1. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433–440. - PubMed
    1. Kerver AJ, Rommes JH, Mevissen-Verhage EA, Hulstaert PF, Vos A, Verhoef J, Wittebol P. Colonization and infection in surgical intensive care patients – a prospective study. Intensive Care Med. 1987;13:347–351. doi: 10.1007/BF00255792. - DOI - PubMed
    1. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159:1249–1256. - PubMed
    1. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115–2121. doi: 10.1378/chest.122.6.2115. - DOI - PubMed
    1. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med. 2005;33:2184–2193. doi: 10.1097/01.CCM.0000181731.53912.D9. - DOI - PubMed

MeSH terms

Feedback